Genentech builds $750M OR facility; Bavarian Nordic delays Lyme vaccine to 2028; Xspray gets 2nd CRL for Dasynoc over NerPharMa manufacturing issues.
August 21, 2026 10:52 AM EDT
News Briefing
Genentech invests $750M in new factory; Bavarian Nordic delays Lyme vaccine trial
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Think we're worth reading - tell Google.
Atea's BEM/RZR matches Gilead's Epclusa in Phase 3; AbCellera partners with Vertex for $28M; LB Pharma raises $150M for…
Vertex's Casgevy wins pediatric approval, United Therapeutics buys Thymmune for up to $300M, plus deals from Insilico, Fosun and…
Incyte drops JAK2 drug INCB160058 after data review; Oak Hill Bio merges with RA Capital SPAC for $175M; Innocare's…
Cartesian’s $150M financing; Editas Medicine’s money moves
Trial results for Lilly's "triple-G" drug, FDA's leadership purge leaves chaos, and more biotech news from The Readout
Pfizer’s experimental 25-valent pneumococcal shot beats Prevnar 20; Relay Therapeutics charts $175M offering; Lilly to pay up to…
